{"id":10824,"date":"2025-08-27T22:29:43","date_gmt":"2025-08-27T19:29:43","guid":{"rendered":"https:\/\/dryavuzbesogul.com\/antikoagulan\/"},"modified":"2025-09-02T13:49:30","modified_gmt":"2025-09-02T10:49:30","slug":"antikoagulan","status":"publish","type":"post","link":"https:\/\/dryavuzbesogul.com\/en\/antikoagulan\/","title":{"rendered":"Blood Thinners | Anticoagulants"},"content":{"rendered":"

Anticoagulants are medications that prevent abnormal blood clot formation by inhibiting specific steps in the coagulation cascade. They are essential in treating and preventing conditions such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, and stroke.<\/span><\/p>\n

Traditional anticoagulants like warfarin require frequent monitoring of INR values to maintain therapeutic efficacy and avoid bleeding risks. Newer direct oral anticoagulants (DOACs) provide more predictable effects without routine monitoring, improving patient convenience.<\/span><\/p>\n

The choice of anticoagulant depends on underlying disease, renal function, comorbidities, and drug interactions. Individualized therapy ensures both effective thromboprophylaxis and minimal risk of hemorrhagic complications.<\/span><\/p>\n

Patients on anticoagulant therapy should be closely monitored for signs of bleeding, drug interactions, and compliance. Education regarding medication adherence and regular follow-up visits play a critical role in ensuring safe and effective treatment outcomes.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n
Medical Name<\/td>\nAnticoagulant Drugs (Blood Thinners)<\/td>\n<\/tr>\n
Frequent Use Areas<\/td>\n– Treatment of deep vein thrombosis (DVT) and pulmonary embolism- Atrial fibrillation- Heart valve diseases- Stent applications<\/td>\n<\/tr>\n
Causes<\/td>\n– Prevent or treat blood clots<\/td>\n<\/tr>\n
Risk Factors<\/td>\n– Coagulation disorders- Long-term immobility- Heart rhythm disorders- Presence of stent or prosthetic valve<\/td>\n<\/tr>\n
Complications<\/td>\n– Risk of bleeding (internal and external bleeding)- Bruises on the skin- Rarely impaired liver or kidney function<\/td>\n<\/tr>\n
Diagnostic Methods<\/td>\n– Blood tests (INR, aPTT, anti-Xa level, kidney and liver functions)- Clinical evaluation<\/td>\n<\/tr>\n
Treatment Methods<\/td>\n– Warfarin, heparin, low molecular weight heparin, new generation oral anticoagulants (NOAC\/DOAC)<\/td>\n<\/tr>\n
Prevention Methods<\/td>\n– Regular blood tests and follow-up- Not changing the dose without doctor’s recommendation- Protection from falls and traumas<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n
\n

Yaz\u0131 \u0130\u00e7eri\u011fi<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n